Details of the Drug

General Information of Drug (ID: DM3D8GV)

Drug Name

MEDI-0639

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01577745) A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors. U.S. National Institutes of Health.